MedPath

Application of glomerular filtration rate decline rate to Optimize Timing of Pre-emptive Arteriovenous fistula Creation for Chronic Kidney Disease Patients

Completed
Conditions
CKD G5, eGFR below 15 ml/min/1.73 m2 which plan for AVF operations.
Pre-emptive arteriovenous fistula, Chronic kidney disease, GFR trajectory
Registration Number
TCTR20240326006
Lead Sponsor
aresuan University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
71
Inclusion Criteria

encompassed subjects without peripheral artery disease in the upper extremity and with sufficient vein quality confirmed through duplex ultrasonography prior to AVF creation. A uniform pre-operative assessment of vessel quality was carried out using duplex ultrasound in both institutions. The assessment followed the criteria set forth in the KDOQI guideline 2006, which specifies that vessel quality is determined by an arterial diameter exceeding 2.5 mm with a detectable distal pulse, and a superficial vein diameter of over 3 mm with consistent integrity. These criteria establish the suitability for autogenous arteriovenous fistula (AVF) creation.

Exclusion Criteria

patients with incomplete eGFR data within the 12 months preceding referral for AVF creation, those who passed away before initiating hemodialysis, and individuals with acute illness and acute kidney injury without recovery to baseline GFR.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The time remaining before the initiation of hemodialysis until 31st Dec 2022 days at baseline, 2 mo, 4 mo, 6 mo, 8 mo, 10 mo, and 12 mo before starting hemodialysis
Secondary Outcome Measures
NameTimeMethod
A functioning arteriovenous fistula (AVF) until 31st Dec 2022 Binary outcome (Yes/No) at baseline, 2 mo, 4 mo, 6 mo, 8 mo, 10 mo, and 12 mo before starting hemodialysis
© Copyright 2025. All Rights Reserved by MedPath